COMMUNIQUÉS West-GlobeNewswire

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
18/12/2024
MALVERN, Pa., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”) today announced the granting of inducement awards to a new employee as described below. In accordance with NASDAQ Listing [...]
Amwell CFO Mark Hirschhorn Expands Leadership Role
18/12/2024
Seasoned leader assumes responsibility for operations and sales as COO BOSTON, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in digital care, has announced Chief Financial Officer (CFO) Mark [...]
RemoniHealth Completes 80,000 Remote Monitoring Encounters for Chronic Retina Diseases
18/12/2024
Achieves doubling in remote patient enrollment. Plans Expanded Launch of RH 2.0 Care Management Platform WHITE PLAINS, N.Y., Dec. 18, 2024 (GLOBE NEWSWIRE) -- RemoniHealth, a leading medical technology company providing [...]
AVITA Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
18/12/2024
VALENCIA, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin [...]
NeuroPace to Present at the 43rd Annual J.P. Morgan Healthcare Conference
18/12/2024
MOUNTAIN VIEW, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management [...]
Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management
18/12/2024
MOUNTAIN VIEW, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for the treatment of [...]
Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing Environment
18/12/2024
MONTREAL, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of [...]
Theratechnologies soumet un supplément d'approbation préalable à la FDA pour l’environnement de la fabrication d’EGRIFTA SV(MD)
18/12/2024
MONTRÉAL, 18 déc. 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique axée sur la mise au point et la commercialisation de [...]
KFSHRC Successfully Performs Robotic-Assisted Retroperitoneal Lymph Node Dissection
18/12/2024
RIYADH, Saudia Arabia, Dec. 18, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has achieved a groundbreaking medical milestone in the Middle East by successfully [...]
Spineway wins new approvals in Vietnam and registers initial orders
18/12/2024
Press release Ecully, December 18, 2024 – 6 p.m. Spineway wins new approvals in Vietnam and registers initial orders The Spineway Group, a specialist in innovative implants for the treatment of severe spine disorders, [...]
SPINEWAY obtient de nouvelles homologations au Vietnam et enregistre des premières commandes
18/12/2024
Communiqué de presse Ecully, le 18 décembre 2024 – 18h Spineway obtient de nouvelles homologations au Vietnam et enregistre des premières commandes Le groupe Spineway, spécialiste des implants innovants pour le [...]
OSE Immunotherapeutics to Present Anti-IL-7R Lusvertikimab Phase 2 Induction Results in Ulcerative Colitis at 20th Congress of ECCO
18/12/2024
A clinical abstract on the induction results from the CoTikiS Phase 2 trial of anti-IL-7 Receptor Lusvertikimab in Ulcerative Colitis accepted for Oral Presentation and selected amongst the Top 10 oral abstracts for 20 [...]
OSE Immunotherapeutics présentera les résultats d’induction de Phase 2 de l’anti-IL-7R Lusvertikimab dans la rectocolite hémorragique au 20ème congrès de l’ECCO
18/12/2024
Un abstract clinique sur les résultats d’induction de l’étude de Phase 2 CoTikiS évaluant l’anti-IL-7 récepteur Lusvertikimab dans la rectocolite hémorragique a été accepté pour présentation orale et a été sélectionné [...]
Trinity Biotech Receives Early Approval from the World Health Organization to Begin Offshore Manufacturing of TrinScreen HIV & Uni-Gold HIV
18/12/2024
DUBLIN, Ireland, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable [...]
Public Mental Health Plans Sue State Over Broken Negotiations
18/12/2024
Legal Action Seeks to Protect Services and Secure Fair Contract Terms LANSING, Mich., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Michigan’s public mental health plans, known as Prepaid Inpatient Health Plans (PIHPs), have filed [...]
TigaTx Announces up to $35.5M in Funding from ARPA-H and NIH Awards to Advance First-in-Class Engineered IgA Monoclonal Antibody for Cancer and Infectious Diseases
18/12/2024
TigaTx will use the ARPA-H and NIH funding to progress its lead program, TIGA-001, an IgA anti-EGFR neutrophil engager, into the clinic and generate clinical proof-of-concept data for its engineered IgA platform TigaTx [...]
Olympia Pharmaceuticals Announces the Launch of Sister Brand, Wesley Pharmaceuticals, in Honor of Beloved Employee
18/12/2024
The first location will serve as a new production facility for the company, tripling current production capacity ORLANDO, Fla., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Olympia Pharmaceuticals , a leading innovator in the [...]
Orion and Abilita Therapeutics announce research collaboration and option to license agreement to develop innovative antibody therapeutics
18/12/2024
ORION CORPORATION PRESS RELEASE 18 DECEMBER 2024 at 17.00 EET Orion and Abilita Therapeutics announce research collaboration and option to license agreement to develop innovative antibody therapeutics Orion Corporation [...]
MiNK Therapeutics to Present iNKT Cell Therapy in Gastric Cancer at ASCO GI Annual Meeting
18/12/2024
Presentation will feature the ongoing Phase 2 study of agenT-797 in refractory gastric cancer NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical [...]

Pages